Literature DB >> 18624987

The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance.

Carlo Dani1, Giovanna Bertini, Iuri Corsini, Serena Elia, Venturella Vangi, Simone Pratesi, Firmino F Rubaltelli.   

Abstract

BACKGROUND: Some extremely preterm infants experience spontaneous closure of the ductus arteriosus. On the other side, a high percentage (22-30%) of preterm infants born at the lower gestational age fail to respond to a single course of ibuprofen. AIM: To assess if there are clinical characteristics effective as predictive factors for spontaneous closure of the ductus arteriosus, development of patent ductus arteriosus (PDA) and ibuprofen-resistant PDA.
METHODS: A cohort of inborn infants less than 28 weeks of gestation were prospectively studied. We distinguished infants who had spontaneous closure of ductus arteriosus, who developed PDA and who developed ibuprofen-resistant PDA.
RESULTS: We studied 34 infants. Eight infants (24%) had spontaneous closure of PDA, 17 infants (50%) had a closure of PDA following the first ibuprofen course, while 9 infants (26%) failed to respond to the first ibuprofen course. Infants born at 23-25 weeks of gestation were found to have lower likelihood of PDA spontaneous closure, and higher risk of developing PDA refractory to ibuprofen therapy. Sepsis was found to increase significantly the risk of ibuprofen failure in closing PDA.
CONCLUSION: An important percentage of extremely preterm infants exhibited spontaneous closure of PDA. Among clinical characteristics lowest gestational ages predict PDA and ibuprofen-resistant PDA, while sepsis predicts only ibuprofen-resistant PDA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624987     DOI: 10.1111/j.1651-2227.2008.00871.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  15 in total

1.  The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

Authors:  Jeff Reese; Matthew M Laughon
Journal:  J Pediatr       Date:  2015-08-24       Impact factor: 4.406

2.  Predictors of successful closure of patent ductus arteriosus with indomethacin.

Authors:  M F Ahamed; P Verma; S Lee; M Vega; D Wang; M Kim; M Fuloria
Journal:  J Perinatol       Date:  2015-04-09       Impact factor: 2.521

Review 3.  Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.

Authors:  Yang Hu; Hongfang Jin; Yi Jiang; Junbao Du
Journal:  Pediatr Cardiol       Date:  2018-02-21       Impact factor: 1.655

4.  Oral Paracetamol for Patent Ductus Arteriosus Rescue Closure.

Authors:  Pramod Pharande; Hadley Watson; Kenneth Tan; Arvind Sehgal
Journal:  Pediatr Cardiol       Date:  2017-10-17       Impact factor: 1.655

5.  Aminoglycoside-mediated relaxation of the ductus arteriosus in sepsis-associated PDA.

Authors:  Megan M Vucovich; Robert B Cotton; Elaine L Shelton; Jeremy A Goettel; Noah J Ehinger; Stanley D Poole; Naoko Brown; James L Wynn; Bibhash C Paria; James C Slaughter; Reese H Clark; Mario A Rojas; Jeff Reese
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

6.  Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.

Authors:  Lynda Adrouche-Amrani; Robert S Green; Karen M Gluck; Jing Lin
Journal:  BMC Pediatr       Date:  2012-01-27       Impact factor: 2.125

7.  Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure.

Authors:  Daniëlla W E Roofthooft; Ingrid M van Beynum; Johan C A de Klerk; Monique van Dijk; John N van den Anker; Irwin K M Reiss; Dick Tibboel; Sinno H P Simons
Journal:  Eur J Pediatr       Date:  2015-04-30       Impact factor: 3.183

8.  Ibuprofen for Ductus Arteriosus Months after Birth.

Authors:  Odile Frauenfelder; Ingrid M van Beynum; Irwin K M Reiss; Sinno H P Simons
Journal:  Case Rep Pediatr       Date:  2016-06-14

9.  Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates.

Authors:  Mehdi Ghaderian; Amir Mohammad Armanian; Mohammad Reza Sabri; Mojtaba Montaseri
Journal:  J Res Med Sci       Date:  2019-02-25       Impact factor: 1.852

10.  Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates.

Authors:  Gianluca Terrin; Francesca Conte; Antonella Scipione; Erica Bacchio; Maria Giulia Conti; Rosalia Ferro; Flavia Ventriglia; Mario De Curtis
Journal:  Ital J Pediatr       Date:  2014-02-20       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.